Publicacións en colaboración con investigadores/as de University of Michigan Medical School (10)

2024

  1. A genome-wide association meta-analysis of all-cause and vascular dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995

  2. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. Lipodystrophy Prevalence, “Lipodystrophy-Like Phenotypes,” and Diagnostic Challenges

    Diabetes

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2019

  1. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy

    Endocrine, Vol. 64, Núm. 3, pp. 500-511

2018

  1. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy

    Endocrine, Vol. 60, Núm. 3, pp. 479-489

2017

  1. Estimating the prevalence of generalized and partial lipodystrophy: Findings and challenges

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 10, pp. 375-383

2016

  1. The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460